Exploring the Antiproliferative Potency of Pyrido[2,3-d]Pyrimidine Derivatives: Studies on Design, Synthesis, Anticancer Evaluation, SAR, Docking, and DFT Calculations.
Autor: | Abd-Alsalam E; Chemistry Department, Faculty of Science, Ain shams University, Abbassia, 11566, Cairo, Egypt., Hafez HN; National Research Center, Photochemistry Department (Heterocyclic Unit), Dokki, 12622, Cairo, Egypt., Assay MG; Chemistry Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt., Ali AK; Chemistry Department, Faculty of Science, Ain shams University, Abbassia, 11566, Cairo, Egypt., El-Farargy AF; Chemistry Department, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt., Abbass EM; Chemistry Department, Faculty of Science, Ain shams University, Abbassia, 11566, Cairo, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | Chemistry & biodiversity [Chem Biodivers] 2024 Feb; Vol. 21 (2), pp. e202301682. Date of Electronic Publication: 2024 Jan 11. |
DOI: | 10.1002/cbdv.202301682 |
Abstrakt: | Herein, an efficient method for the synthesis of a new series of pyrido[2,3-d]pyrimidine derivatives has been adopted through the reaction of hydrazinyl pyrido[2,3-d] pyrimidine derivative (1) with different electrophilic species, such as ethyl cyanoacetate and different 1,3 diketone derivatives, gave the corresponding derivatives (2-5). Meanwhile, pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidines (6-11) were synthesized via reaction of hydrazine derivative 1 with phenylisothiocyanate, potassium thiocyanate, and carbon disulfide. Compound 1 was also submitted to react with different carbonyl compounds to afford pyrido-pyrimidine derivatives (12-15). All the newly synthesized compounds were tested in vitro for their antiproliferative activities against HCT-116 and MCF-7 cell lines. Compounds 2, 3, 7, and 8 displayed very strong inhibitory activity against the two cell lines compared with the standard drug doxorubicin. Furthermore, a docking study of the most active compounds was performed with the thymidylate synthase enzyme (PDB: Code 6qxg). Moreover, DFT calculation was carried out for the most biologically active compounds and a reference drug (Doxorubicin) using the B3LYP/6-31G+(d,p) level of theory. The calculated E (© 2023 Wiley-VHCA AG, Zurich, Switzerland.) |
Databáze: | MEDLINE |
Externí odkaz: |